Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

AbbVie's key product revenues from 2016 to 2018 (in million U.S. dollars)*
AbbVie's key product revenues 2016-2018
AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. As of 2018, the company’s top revenue generating drug was Humira. During that year Humira generated about 19.9 billion U.S. dollars in revenue for AbbVie. Humira is used to treat several types of autoimmune diseases including certain types of arthritis and Crohn’s disease. The second highest revenue generating drug for the company was Imbruvica, though it generated significantly less revenue that Humira.

AbbVie’s company profile

Abbvie was founded in 2013, originally a spin-off of Abbott Laboratories, and is based out of Chicago, Illinois, in the United States. In recent years the company has experience some growth which can also be seen in their increasing number of employees. The company has also experienced exceptional growth in their yearly revenue earnings. Finally, AbbVie has experienced significant growth in its total assets in recent years.

AbbVie’s global positioning

Despite being a young company, it is clear that AbbVie is among the top pharmaceutical companies. AbbVie is placed among other top companies such as Pfizer and Johnson & Johnson in terms of their prescription sales and expenditure on research and development. The company is also among the top pharmaceutical companies in terms of its net profits per employee.
AbbVie's key product revenues from 2016 to 2018 (in million U.S. dollars)*
201620172018
----
----
----
----
----
----
----
----
----
----
----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2016 to 2018

Supplementary notes

Open this statistic in...
AbbVie's key product revenues 2016-2018
AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. As of 2018, the company’s top revenue generating drug was Humira. During that year Humira generated about 19.9 billion U.S. dollars in revenue for AbbVie. Humira is used to treat several types of autoimmune diseases including certain types of arthritis and Crohn’s disease. The second highest revenue generating drug for the company was Imbruvica, though it generated significantly less revenue that Humira.

AbbVie’s company profile

Abbvie was founded in 2013, originally a spin-off of Abbott Laboratories, and is based out of Chicago, Illinois, in the United States. In recent years the company has experience some growth which can also be seen in their increasing number of employees. The company has also experienced exceptional growth in their yearly revenue earnings. Finally, AbbVie has experienced significant growth in its total assets in recent years.

AbbVie’s global positioning

Despite being a young company, it is clear that AbbVie is among the top pharmaceutical companies. AbbVie is placed among other top companies such as Pfizer and Johnson & Johnson in terms of their prescription sales and expenditure on research and development. The company is also among the top pharmaceutical companies in terms of its net profits per employee.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical brands: Humira (AbbVie)"
  • Overview
  • Drug prices and consumer behavior
  • Advertising expenditures
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.